Literature DB >> 11700189

Hearing loss in children with Down syndrome.

S R Shott1, A Joseph, D Heithaus.   

Abstract

OBJECTIVE: Previous studies report a 38-78% incidence of hearing loss in children with Down syndrome (DS). The purpose of this study was to establish more up to date information about hearing loss in children with DS.
METHODS: A 5-year longitudinal study following the otolaryngologic problems seen in children with DS was initiated in February, 1999 at the Children's Hospital Medical Center in Cincinnati, OH. Aggressive, 'state of the art' treatment, both medical and surgical, was provided to a group of children, (n=48), all of whom were entered into the study at an age under 2 years. Specific interventions and treatments were reviewed in regards to following and treating the children's chronic ear disease. Hearing level results at the end of the first year of the study were evaluated in this publication. This includes both pre-treatment and post-treatment audiologic results.
RESULTS: After treatment of easily reversible hearing loss from chronic otitis media, either with medical or surgical treatment with PET's, 98% of the children had normal hearing levels. Only two children had residual mild hearing losses after treatment interventions.
CONCLUSION: Aggressive, meticulous and compulsive diagnosis and treatment of chronic ear disease in children with DS, started soon after birth, provides significantly improved hearing levels than reported previously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700189     DOI: 10.1016/s0165-5876(01)00572-9

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  21 in total

1.  Language Characteristics of Individuals with Down Syndrome.

Authors:  Gary E Martin; Jessica Klusek; Bruno Estigarribia; Joanne E Roberts
Journal:  Top Lang Disord       Date:  2009-04

2.  [Hearing impairment in children and adolescents with Down's syndrome].

Authors:  C Hess; F Rosanowski; U Eysholdt; M Schuster
Journal:  HNO       Date:  2006-03       Impact factor: 1.284

Review 3.  Speech impairment in Down syndrome: a review.

Authors:  Ray D Kent; Houri K Vorperian
Journal:  J Speech Lang Hear Res       Date:  2012-12-28       Impact factor: 2.297

4.  Inner ear anomalies seen on CT images in people with Down syndrome.

Authors:  Jarunee Intrapiromkul; Nafi Aygun; David E Tunkel; Marco Carone; David M Yousem
Journal:  Pediatr Radiol       Date:  2012-08-31

5.  RIPPLY3 is a retinoic acid-inducible repressor required for setting the borders of the pre-placodal ectoderm.

Authors:  Amanda Janesick; Jason Shiotsugu; Mao Taketani; Bruce Blumberg
Journal:  Development       Date:  2012-03       Impact factor: 6.868

6.  A cross-sectional analysis of otitis media with effusion in children with Down syndrome.

Authors:  M Maris; M Wojciechowski; P Van de Heyning; An Boudewyns
Journal:  Eur J Pediatr       Date:  2014-05-10       Impact factor: 3.183

7.  Wideband acoustic immittance in children with Down syndrome: prediction of middle-ear dysfunction, conductive hearing loss and patent PE tubes.

Authors:  Lisa L Hunter; Douglas H Keefe; M Patrick Feeney; David K Brown; Jareen Meinzen-Derr; Alaaeldin M Elsayed; Julia M Amann; Vairavan Manickam; Denis Fitzpatrick; Sally R Shott
Journal:  Int J Audiol       Date:  2017-04-22       Impact factor: 2.117

8.  Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.

Authors:  Amy M Linabery; Cindy K Blair; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254

Review 9.  Contemporary concepts in management of acute otitis media in children.

Authors:  Eleni Rettig; David E Tunkel
Journal:  Otolaryngol Clin North Am       Date:  2014-08-01       Impact factor: 3.346

Review 10.  Down syndrome.

Authors:  Stylianos E Antonarakis; Brian G Skotko; Michael S Rafii; Andre Strydom; Sarah E Pape; Diana W Bianchi; Stephanie L Sherman; Roger H Reeves
Journal:  Nat Rev Dis Primers       Date:  2020-02-06       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.